Evaluating the Risks & Benefits of Immunosuppression in Patients Prior to Gene Therapy Treatment

Time: 9:00 am
day: Day Two


  • Tackling pre-existing immunity by utilizing enzymes to cleave IgGs in the blood that exist for the capsid
  • Understanding the optimal time within the treatment phase to dose withb Immunosuppressants
  • Exploring the ability to redose patients after immunosuppression treatments